Grand Pharmaceutical Group Limited (HKG:0512)

HKG:0512 Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,341	1,340	1,444	1,753	1,837
Short-Term Investments	591.33	796.38	824.22	638.52	259.16
Trading Asset Securities	1,800	1,135	1,070	1,113	520.77
Cash & Short-Term Investments	3,732	3,271	3,338	3,504	2,617
Cash Growth	14.11%	-2.02%	-4.74%	33.93%	131.32%
Accounts Receivable	2,642	2,068	1,947	1,810	1,544
Other Receivables	280.34	256.18	259.44	225.82	126.93
Receivables	2,923	2,324	2,207	2,149	1,716
Inventory	1,371	1,389	1,340	1,117	955.31
Other Current Assets	-	32.67	1.36	7.65	30.91
Total Current Assets	8,026	7,016	6,887	6,779	5,319
Property, Plant & Equipment	4,266	3,986	3,942	3,802	3,410
Long-Term Investments	8,039	8,222	8,271	8,212	6,304
Goodwill	1,300	588.62	644.05	596.75	505.57
Other Intangible Assets	2,083	1,657	1,398	1,010	881.84
Long-Term Deferred Tax Assets	33.46	25.11	24.59	24.61	25.16
Other Long-Term Assets	1,245	1,021	1,204	633.26	424.29
Total Assets	24,991	22,515	22,371	21,057	16,984
Accounts Payable	1,217	1,330	872.86	734.5	662.49
Accrued Expenses	1,711	1,499	1,615	2,137	1,477
Short-Term Debt	-	-	-	-	57.58
Current Portion of Long-Term Debt	3,130	2,320	3,245	2,127	1,571
Current Portion of Leases	18.32	34.61	9.79	5.73	6.2
Current Income Taxes Payable	241.27	332.06	369.74	354.55	259.87
Current Unearned Revenue	242.72	198.17	318.82	202.11	269.05
Other Current Liabilities	13.15	16.58	22.67	4.83	-
Total Current Liabilities	6,573	5,731	6,455	5,566	4,303
Long-Term Debt	1,256	990.03	1,162	1,510	798.56
Long-Term Leases	40.6	61.61	60.08	13.31	15.16
Long-Term Unearned Revenue	295.37	240.11	265.28	326.82	341.61
Long-Term Deferred Tax Liabilities	300.35	221.63	220.15	197.85	181.88
Total Liabilities	8,466	7,245	8,162	7,614	5,640
Common Stock	35.5	35.5	35.5	35.5	35.5
Additional Paid-In Capital	6,644	6,644	6,644	6,644	6,644
Retained Earnings	11,125	9,567	8,184	6,495	4,483
Treasury Stock	-268.5	-268.5	-187.49	-143.5	-
Comprehensive Income & Other	-1,063	-820.62	-535.96	361.32	76.8
Total Common Equity	16,473	15,158	14,140	13,393	11,240
Minority Interest	52.13	112.8	68.32	50.23	104.71
Shareholders' Equity	16,525	15,271	14,209	13,443	11,344
Total Liabilities & Equity	24,991	22,515	22,371	21,057	16,984
Total Debt	4,445	3,407	4,478	3,656	2,448
Net Cash (Debt)	-712.6	-135.89	-1,139	-151.9	168.34
Net Cash Per Share	-0.20	-0.04	-0.32	-0.04	0.05
Filing Date Shares Outstanding	3,502	3,502	3,519	3,527	3,550
Total Common Shares Outstanding	3,502	3,502	3,519	3,527	3,550
Working Capital	1,452	1,285	432.32	1,212	1,016
Book Value Per Share	4.70	4.33	4.02	3.80	3.17
Tangible Book Value	13,091	12,912	12,098	11,786	9,852
Tangible Book Value Per Share	3.74	3.69	3.44	3.34	2.78
Land	1.6	1.65	1.7	1.84	1.78
Buildings	2,573	2,476	2,337	2,357	1,992
Machinery	2,935	2,785	2,581	2,440	2,147
Construction In Progress	672.93	410.17	551.34	457.81	482.09

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.